Home

SCOPIA CAPITAL MANAGEMENT LP

CIK 1279150 · last filed 2019-05-30

SCOPIA CAPITAL MANAGEMENT LP is a corporate insider who has filed 27 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing shows the insider sold $7.1M of ITRI on May 30, 2019. Across all open-market trades the lifetime net is +$119.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $597.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$597.43M

Companies

4

Total Filings

27

Lifetime Open-Market Net

$119.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ITRI 10%+ Owner 3,926,804 $83.93 $329.58M $164.32M 11 2019-05-30
Acorda Therapeutics, Inc. (ACOR) Delisted 10%+ Owner 39,643 $0.66 $26.2K -$49.11M 9 2019-01-28
Barzel Industries Inc. (TONSW) Delisted 10%+ Owner 2,634,673 — — $0 1 2008-08-13
CENT 10%+ Owner 6,232,134 $42.98 $267.86M $3.83M 6 2008-05-23

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-05-30 ITRI Sell (S) −124,576 -$7.14M EDGAR
2019-05-28 ITRI Sell (S) −193,580 -$10.98M EDGAR
2019-04-11 ITRI Sell (S) −328 -$15.7K EDGAR
2019-04-09 ITRI Sell (S) −18,700 -$898.2K EDGAR
2019-01-28 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −44,004 -$705.1K EDGAR
2019-01-24 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −391,372 -$6.27M EDGAR
2018-12-21 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −180,000 -$2.56M EDGAR
2018-12-19 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −487,412 -$8.18M EDGAR
2018-12-17 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −247,428 -$4.01M EDGAR
2018-11-16 ITRI Sell (S) −220,712 -$11.63M EDGAR
Showing 1–10 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.